logo
  

Bausch Announces Approval Of VYZULTA In Brazil - Quick Facts

Bausch Health Companies Inc. (BHC), Bausch + Lomb, and Nicox announced VYZULTA, 0.024%, has received regulatory approval from the Brazilian Health Regulatory Agency. It is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The approval of VYZULTA in Brazil marks its tenth regulatory approval.

VYZULTA, or latanoprostene bunod ophthalmic solution, is now approved in 10 markets, including Argentina, Brazil, Canada, Colombia, Hong Kong, Mexico, South Korea, Taiwan, Ukraine and the United States. Nicox generates revenue from VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cuisine Solutions is recalling its JUST Egg flavored plant-based "bites" products due to undeclared allergens, the U.S. Food and Drug Administration said. The recall involves a limited number of 2-pouch retail packages that may contain an incorrect sealed pouch containing whole-egg and milk products, known allergens. Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023.
Follow RTT